Lotensin Hct Tablet
Product Images NDC 30698-452
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lotensin Hct (NDC 30698-452). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Validus Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Hydrochlorothiazide Structural Formula. (Lotensin Hct 02)
Principal Display Panel 10 mg Benazepril/12.5 mg Hydrochlorothiazide Tabletndc 30698-452-01lotensin Hct® Benazepril HCl Usp 10 mghydrochlorothiazide Usp 12.5 mg10/12.5 100 Tabletsrx Only (Lotensin Hct 03)
Principal Display Panel 20 mg Benazepril/12.5 mg Hydrochlorothiazide Tabletndc 30698-453-01lotensin Hct® 20/12.5benazepril HCl Usp 20 mghydrochlorothiazide Usp 12.5 mg20/12.5100 Tabletsrx Only (Lotensin Hct 04)
This text is a package insert for a drug, containing dosage information and storage instructions. It advises the user to not store the drug above 86°F and to protect it from light. It also includes a warning to keep all drugs out of the reach of children. The drug name and purpose are not available.*
Principal Display Panel 20 mg Benazepril/25 mg Hydrochlorothiazide Tabletndc 30698-454-01lotensin Hct® 20/25benazepril HCl Usp 20 mghydrochlorothiazide Usp 25 mg20/25100 Tabletsrx Only (Lotensin Hct 05)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.